BOPI 06 BR / 2025 REPERTOIRE NUMERIQUE 22 Fig. 3A ________________________________________ (11) 21935 Consulter le mémoire (51) A61K 39/395 (2023.01); A61P 35/00 (2023.01); A61P 37/00 (2023.01); C07K 16/28 (2023.01); C12N 15/13 (2023.01); C12N 15/63 (2023.01) (21) 1202400288 - PCT/CN2023/076131 (22) 15/02/2023 (30) CN n° 2022/076606 du 17/02/2022 (54) ‘‘Anti-IL-13RA2 Monoclonal Antibodies And Uses Thereof’’ (72) LI, Runsheng (CN); HUANG, Wentao (CN); LI, Yifan (CN); LUO, Jie (CN) et LIU, Zhifang (CN) (73) LANOVA MEDICINES DEVELOPMENT CO., LTD, No. 177, Group 6, Rennan Village, Kangqiao Town, Pudong New Area, Shanghai 201315 (CN) (74) SCP ATANGA IP, 88 Boulevard de l'Unité, Akwa, 2e étage Immeuble Tayou, Fokou Douche, B.P. 4663, DOUALA (CM). (57) Provided are antibodies or fragment thereof having binding speeificity to the human interleukin 13 receptor subunit alpha 2 (IL-13RA2) protein. These antibodies are capable of binding to IL13RA2 at high affinity and can mediate antibodydependent cellular cytotoxicity (ADCC) and effectively induce endocytosis. Also provided are methods and uses for treating cancers and inflammatory diseases. ________________________________________ (11) 21936 Consulter le mémoire (51) A01G 25/14 (2023.01); A01M 21/04 (2023.01); A01M 7/00 (2023.01) (21) 1202400300 - PCT/GB2023/050410 (22) 23/02/2023 (30) JP n° 2022-027059 du 24/02/2022 (54) Ready To Use Plant Treatment Agent Applicator, Container And Product. (72) FUJIYAMA Masayasu (JP) (73) 1-UPL CORPORATION LIMITED, 6th Floor, Suite 157B, Harbor Front Building, President John Kennedy Street, PORT LOUIS (MU) et
RkJQdWJsaXNoZXIy MTM1NDc3MA==